Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation

J Exp Ther Oncol. 2012;10(1):1-8.

Abstract

Xanthohumol (XN), a prenylated chalcone present in hops exhibits anti-inflammatory, antioxidant and anticancer activity. In the present study we show that XN inhibits the proliferation of mouse lymphoma cells and IL-2 induced proliferation and cell cycle progression in mouse splenic T cells. The suppression of T cell proliferation by XN was due to the inhibition of IL-2 induced Janus kinase/signal transducers and activators of transcription (Jak/STAT) and extracellular signal-regulated kinase 1 and 2 (Erk1/2) signaling pathways. XN also inhibited proliferation-related cellular proteins such as c-Myc, c-Fos and NF-kappaB and cyclin D1. Thus, understanding of IL-2 induced cell signaling pathways in normal T cells, which are constitutively turned on in T cell lymphomas may facilitate development of XN for the treatment of hematologic cancers.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cell Cycle Proteins / drug effects
  • Cell Cycle Proteins / metabolism
  • Cell Line, Tumor
  • Cell Proliferation* / drug effects
  • Flavonoids / pharmacology*
  • Gene Expression Regulation, Neoplastic / drug effects
  • Interleukin-2 / metabolism*
  • Janus Kinases / metabolism
  • MAP Kinase Signaling System / drug effects
  • Mice
  • Mice, Inbred C57BL
  • Propiophenones / pharmacology*
  • Spleen / cytology
  • Spleen / metabolism
  • T-Lymphocytes* / drug effects
  • T-Lymphocytes* / metabolism

Substances

  • Cell Cycle Proteins
  • Flavonoids
  • Interleukin-2
  • Propiophenones
  • Janus Kinases
  • xanthohumol